Developer docs
API playgroundTry for free, no card

Search company profiles

Reperio Health

Full company profile

uuid0000oij

Namestring
Reperio Health
Legal namestring
Reperio Health, Inc.
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Reperio Health, Inc. is a Portland, Oregon-based, venture-backed private company founded in 2020 that provides at-home preventive health screening kits with instant biometric results. The company's core product, ReperioKit, combines FDA-cleared, CLIA-waived Bluetooth-connected diagnostic devices with a consumer-grade mobile application (iOS and Android) to measure blood pressure, heart rate, BMI, relative fat mass, glucose, total cholesterol, HDL, LDL, and triglycerides, delivering results in under 30 minutes rather than the weeks typical of traditional laboratory workflows. The technology is protected by a registered patent covering instant at-home screening results, which the company claims is unique globally in this category. A companion service, ReperioCare, adds an on-demand virtual preventive care visit where licensed clinicians review screening results, health history, and lifestyle risk factors to provide actionable recommendations; this service can be billed as a preventive insurance claim through employer-sponsored health plans.

The company's revenue model rests on two tiers: a Foundation tier consisting of one-time/perpetual kit sales, and a Recommended tier bundling kits with ReperioCare clinical follow-up on a pay-as-you-go cadence. Pricing is quote-based and not publicly disclosed, and the company sells with no minimum order quantities, one-click ordering, and 24/7 live support. Reperio pursues a dual go-to-market motion: direct enterprise sales to employers and health plans, and direct-to-consumer self-service ordering through its mobile app. Distribution is also augmented by a strategic partnership with Amazon One Medical (announced January 2026) that uses Reperio screening as a catalyst for One Medical membership enrollment.

Reperio's customer base spans employer wellness programs (The Partners Group, CareerPlug, Pella, Bob's Red Mill, Tailored Brands, SMX, SANW), health systems and providers (Vanderbilt Health, Children's Hospital Colorado, Methodist), and health plans/insurers (John Hancock, Presbyterian, PEHP). The company reports outcome metrics including a 200% increase in preventive screening participation versus traditional screenings, a 71% opt-in rate, a 95% customer satisfaction rate, a 48% condition discovery rate, and 4-8x client ROI. ReperioCare operations cover 39 states plus Washington D.C. as of October 2025, with a stated plan to reach all 50 states by 2026. The company is SOC 2 Type II certified and HIPAA-compliant, is led by co-founder and CEO Travis Rush with co-founder Matt Wallington as CTO, and has raised approximately $26.7 million in cumulative disclosed funding across rounds from 2021 through 2025, with Caduceus Capital Partners as lead investor in both the 2021 and 2025 rounds.

Short descriptiontext

Reperio Health provides at-home preventive health screening kits delivering instant biometric results via FDA-cleared Bluetooth devices and a mobile app, serving employers, health plans, and providers with optional on-demand virtual clinician follow-up.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersPortland, United States
HQ citystring
Portland
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
at-home preventive screening, biometric health kits, telehealth virtual visits, employer wellness programs, chronic disease prevention
Industry2 codes
1Cardiology Telemedicine Platforms
CodeHLALAGABPrimaryYes
2Preventive Cardiology & Lipidology
CodeHLAKABAFPrimaryNo
NAICS code3 codes
  • Home Health Care Services62161
  • Offices of Physicians6211
  • Home Health Care Services621610
SIC code3 codes
  • Services-Home Health Care Services8082
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Medical Laboratories8071
Product category
At-Home Preventive Health Screening Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1ReperioKit Sales (Foundation Tier)
TypeOne Time License
Description

At-home preventive screening kits sold to employers and health plans with instant results. No minimum order quantities. Includes one-click ordering, 24/7 live support, aggregate reporting, and data sharing for continuity.

reperiohealth.com
2ReperioCare (Clinical Follow-up)
TypeSubscription Recurring
Description

On-demand virtual preventive care visits bundled with screening kits. Can be billed as a preventive insurance claim for employers' health plans or available via direct invoice.

reperiohealth.com
3Amazon One Medical Partnership Integration
TypeManaged Services
Description

Partnership enabling Reperio-screened individuals to access One Medical memberships. Prospective and current One Medical clients can activate employees using Reperio screening as a catalyst for membership enrollment.

reperiohealth.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Pricing details2 tiers
1Foundation Tier - At-home preventive screening kit with instant results
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Instant results, no minimums, one-click ordering, 24/7 live support, payable via invoice, available anywhere in U.S., aggregate reporting, data sharing for continuity

reperiohealth.com
2ReperioCare - Screening with clinical follow-up virtual visit
ModelSubscriptionBilling cadencePay-as-you-go
Notes

Everything in Foundation tier plus: covered as a preventive insurance claim, on-demand virtual visit at conclusion of screening, completed in under 1 hour, clinician-reviewed results with full health risk assessment, built-in care coordination

reperiohealth.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 2 records shown
1ReperioKit
Description

At-home preventive health screening kit that measures key health indicators including blood pressure, heart rate, BMI, relative fat mass, glucose, total cholesterol, HDL, LDL, and triglycerides, delivering instant results in under 30 minutes.

reperiohealth.com
+1 more record
Core offering1 text field

Reperio Health delivers at-home preventive health screenings through the ReperioKit™ — an FDA-cleared, Bluetooth-connected kit that measures blood pressure, heart rate, BMI, relative fat mass, glucose, total cholesterol, HDL, LDL, and triglycerides in under 30 minutes with instant results via a mobile app. The offering is paired with ReperioCare®, an on-demand virtual preventive care visit where licensed clinicians review screening results and provide care recommendations, billable as a preventive insurance claim for employer health plans.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 200% increase in preventive screening participation versus traditional screenings
+5 more records
Product overview1 text field

Reperio Health offers a unified preventive health platform combining at-home screening hardware (ReperioKit™), a mobile application, and integrated virtual care services (ReperioCare®). Users perform finger-stick blood tests at home, receive biomarker results via the app, and can connect with clinicians for virtual consultations to discuss their health data.

Product and service3 records
1ReperioKit™
CategoryAt-home preventive health screening
Description

At-home preventive health screening kit that measures blood pressure, heart rate, BMI, relative fat mass, glucose (fasting/non-fasting), total cholesterol, HDL, LDL, and triglycerides from a finger-stick blood sample via FDA-cleared Bluetooth-connected devices, delivering biometric results to the mobile app in under 30 minutes.

2ReperioCare®
CategoryTelehealth preventive care
Description

On-demand virtual preventive care visit in which licensed clinicians review ReperioKit screening results, health history, and lifestyle risk factors to provide actionable care recommendations and care coordination. Can be billed as a preventive insurance claim through employer-sponsored health plans.

3Reperio Health Mobile App
CategoryMobile health platform
Description

iOS and Android mobile application that delivers instant screening results, provides guided step-by-step screening instructions, manages kit logistics, enables ReperioCare virtual visits, and supports direct consumer ordering of ReperioKit screening kits.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-28
Description

Partnership announced January 28, 2026 connects at-home health screenings with proactive primary care. Individuals completing Reperio's preventive screening gain direct access to One Medical membership. The collaboration creates a streamlined path from early detection to ongoing primary medical care, combining Reperio's ability to reach distributed populations with One Medical's national hybrid in-person and virtual primary care model.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers9 records
TypeDirect peer
Description

LetsGetChecked provides at-home diagnostic test kits with telehealth follow-up and is a direct competitor in the at-home screening plus virtual clinician consultation model.

TypeDirect peer
Description

Everlywell sells at-home lab-based health tests with optional clinician consults, directly competing in consumer and employer at-home screening.[priMetrick is augmented by Lipsum+ data that wasnt formatted properly] Actually, let me clean this up.

TypeDirect peer
Description

BioIQ provides at-home biometric screening solutions targeting employers and health plans for population health management, directly comparable to Reperio's enterprise screening offering.

TypeBroad incumbent
Description

Quest Diagnostics is a national clinical laboratory network that could bundle at-home preventive screening into its employer/payer programs as a broad incumbent in lab diagnostics.

TypeBroad incumbent
Description

Labcorp operates a national clinical lab franchise with employer wellness offerings; it overlaps with Reperio's screening-plus-phlebotomy/lab channel as a broad incumbent.

TypeBroad incumbent
Description

Teladoc is a large incumbent in virtual care that could expand from acute/specialty telehealth into at-home preventive screening kits and virtual wellness visits.

TypeEmerging player
Description

Forward is a preventive-focused primary care provider with home body scanning; it targets employers and offers membership-based preventive care, partially overlapping with ReperioCare.

TypeEmerging player
Description

Function Health sells membership-based at-home lab testing panels paired with clinician insight, closely paralleling Reperio's annual screening-plus-clinician model.

TypeEmerging player
Description

TytoCare provides connected at-home medical exam kits integrated with telehealth visits for clinical decision support, partially comparable to Reperio's hardware-plus-virtual-visit platform.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers13 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Reperio Health

At-Home Preventive Health Screening Servicesreperiohealth.com

Reperio Health provides at-home preventive health screening kits delivering instant biometric results via FDA-cleared Bluetooth devices and a mobile app, serving employers, health plans, and providers with optional on-demand virtual clinician follow-up.

What Reperio Health does

Reperio Health, Inc. is a Portland, Oregon-based, venture-backed private company founded in 2020 that provides at-home preventive health screening kits with instant biometric results. The company's core product, ReperioKit, combines FDA-cleared, CLIA-waived Bluetooth-connected diagnostic devices with a consumer-grade mobile application (iOS and Android) to measure blood pressure, heart rate, BMI, relative fat mass, glucose, total cholesterol, HDL, LDL, and triglycerides, delivering results in under 30 minutes rather than the weeks typical of traditional laboratory workflows. The technology is protected by a registered patent covering instant at-home screening results, which the company claims is unique globally in this category. A companion service, ReperioCare, adds an on-demand virtual preventive care visit where licensed clinicians review screening results, health history, and lifestyle risk factors to provide actionable recommendations; this service can be billed as a preventive insurance claim through employer-sponsored health plans.

The company's revenue model rests on two tiers: a Foundation tier consisting of one-time/perpetual kit sales, and a Recommended tier bundling kits with ReperioCare clinical follow-up on a pay-as-you-go cadence. Pricing is quote-based and not publicly disclosed, and the company sells with no minimum order quantities, one-click ordering, and 24/7 live support. Reperio pursues a dual go-to-market motion: direct enterprise sales to employers and health plans, and direct-to-consumer self-service ordering through its mobile app. Distribution is also augmented by a strategic partnership with Amazon One Medical (announced January 2026) that uses Reperio screening as a catalyst for One Medical membership enrollment.

Reperio's customer base spans employer wellness programs (The Partners Group, CareerPlug, Pella, Bob's Red Mill, Tailored Brands, SMX, SANW), health systems and providers (Vanderbilt Health, Children's Hospital Colorado, Methodist), and health plans/insurers (John Hancock, Presbyterian, PEHP). The company reports outcome metrics including a 200% increase in preventive screening participation versus traditional screenings, a 71% opt-in rate, a 95% customer satisfaction rate, a 48% condition discovery rate, and 4-8x client ROI. ReperioCare operations cover 39 states plus Washington D.C. as of October 2025, with a stated plan to reach all 50 states by 2026. The company is SOC 2 Type II certified and HIPAA-compliant, is led by co-founder and CEO Travis Rush with co-founder Matt Wallington as CTO, and has raised approximately $26.7 million in cumulative disclosed funding across rounds from 2021 through 2025, with Caduceus Capital Partners as lead investor in both the 2021 and 2025 rounds.

Reperio Health firmographics

Firmographics
Name
Reperio Health
Legal name
Reperio Health, Inc.
Website
https://reperiohealth.com
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
Reperio Health provides at-home preventive health screening kits delivering instant biometric results via FDA-cleared Bluetooth devices and a mobile app, serving employers, health plans, and providers with optional on-demand virtual clinician follow-up.
Ownership category
akta.pro rank

Reperio Health industry classification

Industry
Product category
At-Home Preventive Health Screening Services
NAICS
Home Health Care Services (62161), Offices of Physicians (6211), Home Health Care Services (621610)
SIC
Services-Home Health Care Services (8082), Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Medical Laboratories (8071)
akta.pro primary industry
Cardiology Telemedicine Platforms (HLALAGAB)
akta.pro secondary industry
Preventive Cardiology & Lipidology (HLAKABAF)

Keywords

  • At-home preventive screening
  • Biometric health kits
  • Telehealth virtual visits
  • Employer wellness programs
  • Chronic disease prevention

Where Reperio Health is headquartered

Location

Headquarters

HQ city
Portland
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Reperio Health business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. ReperioKit Sales (Foundation Tier): At-home preventive screening kits sold to employers and health plans with instant results. No minimum order quantities. Includes one-click ordering, 24/7 live support, aggregate reporting, and data sharing for continuity.
  2. ReperioCare (Clinical Follow-up): On-demand virtual preventive care visits bundled with screening kits. Can be billed as a preventive insurance claim for employers' health plans or available via direct invoice.
  3. Amazon One Medical Partnership Integration: Partnership enabling Reperio-screened individuals to access One Medical memberships. Prospective and current One Medical clients can activate employees using Reperio screening as a catalyst for membership enrollment.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goFoundation Tier - At-home preventive screening kit with instant results
SubscriptionPay-as-you-goReperioCare - Screening with clinical follow-up virtual visit

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Reperio Health product offering

Product offering

Core offering

Reperio Health delivers at-home preventive health screenings through the ReperioKit™ — an FDA-cleared, Bluetooth-connected kit that measures blood pressure, heart rate, BMI, relative fat mass, glucose, total cholesterol, HDL, LDL, and triglycerides in under 30 minutes with instant results via a mobile app. The offering is paired with ReperioCare®, an on-demand virtual preventive care visit where licensed clinicians review screening results and provide care recommendations, billable as a preventive insurance claim for employer health plans.

Product overview

Reperio Health offers a unified preventive health platform combining at-home screening hardware (ReperioKit™), a mobile application, and integrated virtual care services (ReperioCare®). Users perform finger-stick blood tests at home, receive biomarker results via the app, and can connect with clinicians for virtual consultations to discuss their health data.

Differentiator

Problem solved

Functional benefit

Brands

  • ReperioKit: At-home preventive health screening kit that measures key health indicators including blood pressure, heart rate, BMI, relative fat mass, glucose, total cholesterol, HDL, LDL, and triglycerides, delivering instant results in under 30 minutes.
  • ReperioCare

Products and services

  • ReperioKit™ At-home preventive health screening kit that measures blood pressure, heart rate, BMI, relative fat mass, glucose (fasting/non-fasting), total cholesterol, HDL, LDL, and triglycerides from a finger-stick blood sample via FDA-cleared Bluetooth-connected devices, delivering biometric results to the mobile app in under 30 minutes.
  • ReperioCare® On-demand virtual preventive care visit in which licensed clinicians review ReperioKit screening results, health history, and lifestyle risk factors to provide actionable care recommendations and care coordination. Can be billed as a preventive insurance claim through employer-sponsored health plans.
  • Reperio Health Mobile App iOS and Android mobile application that delivers instant screening results, provides guided step-by-step screening instructions, manages kit logistics, enables ReperioCare virtual visits, and supports direct consumer ordering of ReperioKit screening kits.

Quantifiable outcome

  • 200% increase in preventive screening participation versus traditional screenings
  • +5 more outcomes

Companies that use Reperio Health

Customer profile

Named customers13 records

Segments4 records

Ideal customer profiles4 records

Reperio Health technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Reperio Health partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Amazon One MedicalcoreStrategic or Co-development Partner · 28 January 2026Partnership announced January 28, 2026 connects at-home health screenings with proactive primary care. Individuals completing Reperio's preventive screening gain direct access to One Medical membership. The collaboration creates a streamlined path from early detection to ongoing primary medical care, combining Reperio's ability to reach distributed populations with One Medical's national hybrid in-person and virtual primary care model.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

Reperio Health competitors and assessment

Company assessment

Direct peers

  • LetsGetChecked: LetsGetChecked provides at-home diagnostic test kits with telehealth follow-up and is a direct competitor in the at-home screening plus virtual clinician consultation model.
  • Everlywell: Everlywell sells at-home lab-based health tests with optional clinician consults, directly competing in consumer and employer at-home screening.[priMetrick is augmented by Lipsum+ data that wasnt formatted properly] Actually, let me clean this up.
  • BioIQ: BioIQ provides at-home biometric screening solutions targeting employers and health plans for population health management, directly comparable to Reperio's enterprise screening offering.

Broad incumbents

  • Quest Diagnostics: Quest Diagnostics is a national clinical laboratory network that could bundle at-home preventive screening into its employer/payer programs as a broad incumbent in lab diagnostics.
  • Labcorp: Labcorp operates a national clinical lab franchise with employer wellness offerings; it overlaps with Reperio's screening-plus-phlebotomy/lab channel as a broad incumbent.
  • Teladoc Health: Teladoc is a large incumbent in virtual care that could expand from acute/specialty telehealth into at-home preventive screening kits and virtual wellness visits.

Emerging players

  • Forward Health: Forward is a preventive-focused primary care provider with home body scanning; it targets employers and offers membership-based preventive care, partially overlapping with ReperioCare.
  • Function Health: Function Health sells membership-based at-home lab testing panels paired with clinician insight, closely paralleling Reperio's annual screening-plus-clinician model.
  • TytoCare: TytoCare provides connected at-home medical exam kits integrated with telehealth visits for clinical decision support, partially comparable to Reperio's hardware-plus-virtual-visit platform.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Reperio Health social profiles

Digital presence

Reperio Health compliance and trust

Trust signal

Compliance1 record

Reperio Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Reperio Health leadership team

Management profile

Number of profiles

Profiles9 records

Reperio Health funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Reperio Health M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Reperio Health

What does Reperio Health do?

Reperio Health delivers at-home preventive health screenings through the ReperioKit™ — an FDA-cleared, Bluetooth-connected kit that measures blood pressure, heart rate, BMI, relative fat mass, glucose, total cholesterol, HDL, LDL, and triglycerides in under 30 minutes with instant results via a mobile app. The offering is paired with ReperioCare®, an on-demand virtual preventive care visit where licensed clinicians review screening results and provide care recommendations, billable as a preventive insurance claim for employer health plans.

Is Reperio Health a public or private company?

Reperio Health is a private company. It is classified as venture growth investor backed and is currently operating.

When was Reperio Health founded?

Reperio Health was founded in 2020. It employs 11 to 50 people.

Where is Reperio Health based?

Reperio Health is headquartered in Portland, United States, in the North America region.

How does Reperio Health make money?

Three revenue lines are on record. ReperioKit Sales (Foundation Tier) is the primary driver. The others are reperioCare (Clinical Follow-up) and amazon One Medical Partnership Integration.

Who are Reperio Health's main competitors?

Direct peers on record are LetsGetChecked, Everlywell and BioIQ. Broad incumbents are Quest Diagnostics, Labcorp and Teladoc Health. Emerging players are Forward Health, Function Health and TytoCare.

Does Reperio Health have an API?

No public API is recorded for Reperio Health.

What industry is Reperio Health in?

Reperio Health's product category is At-Home Preventive Health Screening Services. Its primary akta.pro industry code is HLALAGAB, Cardiology Telemedicine Platforms, with a secondary code of HLAKABAF, Preventive Cardiology & Lipidology. Its NAICS code is 62161 and its SIC code is 8082.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FierceHealthcareBringing preventive care into the homeReperio Health is addressing the gap in interpretability of consumer wearable health data by combining at-home screenings, an app, and virtual clinical visits. The company's co-founder and CEO, Travis Rush, explains this integrated approach to helping patients understand their health insights.McknightshomecareOne Medical-Reperio partnership combines health screenings at home with ongoing careOne Medical and Reperio announced a partnership that combines home health screenings with ongoing care. The article does not specify further details or implications.MobiHealthNewsAmazon One Medical partners with Reperio Health for at-home preventive screeningsAmazon's One Medical has partnered with Portland-based preventive care provider Reperio Health to offer at-home health screenings alongside One Medical's hybrid primary care services. The FDA-cleared ReperioKit analyzes blood pressure, glucose, cholesterol, and other metrics, allowing users to connect to licensed clinicians and access One Medical membership for ongoing care if needed. Reperio Health previously secured $14 million in funding last year to expand nationally beyond Oregon and Washington.Business Wire BlogReperio Health and Amazon One Medical Redefine the Front Door to Primary CareReperio Health and Amazon One Medical announced a new partnership connecting at-home health screenings with proactive primary care services. Reperio's FDA-cleared screening kit delivers instant results for key biometric metrics including blood pressure, blood glucose, and cholesterol panels within 30 minutes to 1 hour, with users gaining direct access to One Medical's national hybrid in-person and virtual primary care membership. The collaboration aims to expand preventive care access through employer and health plan channels, targeting hybrid and hard-to-reach workforces while reducing downstream healthcare costs.PharmiWeb.comReperio Health Deepens National Footprint, Adds Industry Vets to Drive At-Home Preventive Care AccessReperio Health announced two leadership additions—Larry Cohen, a former Optum executive, and Jocelyne Wood—as its ReperioCare™ telehealth consultation service expands to 39 states and Washington, D.C., with nationwide coverage expected before 2026. The company's at-home screening kit, ReperioKit™, is already available in all 50 states and delivers instant results for heart health, metabolic function, and other biomarkers within an hour. Reperio Health secured a $14 million funding round in early 2025 to support the national expansion of its integrated screening and telehealth model targeting employers and health plans.BenefitnewsThese technology-driven healthcare benefits are improving access to careHealthcare technology companies Sword Health, LainaHealth, Complement 1, Reperio Health, and WIN are launching new AI-driven and digital tools to improve employee access to care for conditions such as musculoskeletal disorders, cancer, heart disease, and high-risk pregnancies. These platforms aim to reduce administrative burdens on providers, lower healthcare costs for employers, and remove geographic or logistical barriers to preventative and specialized treatment.SecSEC FORM DThe Securities and Exchange Commission is made aware of a new Form D filing by Reperio Health, Inc., indicating an offering of securities worth up to $8.5 million. The filing states that as of the notice date, $5.12 million has been sold, with a remaining amount of $3.38 million yet to be sold. This offering does not involve a business combination transaction.SecSEC FORM DReperio Health, Inc. filed a Form D with the SEC to announce an exempt offering of securities under Rule 506(b). The company is raising a total of $4,000,000 in equity, with $1,000,000 already sold and one investor participating as of May 23, 2024. The filing indicates the offering is intended to last less than one year with no sales commissions or finder's fees.GlobeNewswireReperio Health Recognized for Digital Health Innovation in 8th Annual MedTech Breakthrough Awards ProgramReperio Health won the Best In-Home Testing Solution award in the 8th annual MedTech Breakthrough Awards. The company reported 500% year-over-year growth in 2023 and plans to expand internationally to Canada and Europe.GeekWireIn-home health screening startup Reperio raises $14M, inks deal with UberReperio Health raised $14 million in new funding and signed an agreement with Uber to deliver health screening kits within an hour. The startup, which offers at-home blood and vitals tests, has shipped thousands of kits with over 90% completion rates. It plans to expand services, including nurse-practitioner consultations and AI-driven follow-up.